Jerry Simecka public CV

Jerry Simecka, PhD

Regents Professor, Pharmaceutical Sciences
Associate Dean for Research, UNT System College of Pharmacy

EmailJerry.Simecka@unthsc.edu

Source: Scopus
Calculated based on no. of publications stored in Pure and citations from Scopus

Research activity per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Area of Expertise

Pre-Clinical Services evaluate new therapies against infections using animal models. These studies are done in collaboration with pharmaceutical and academic researchers, and several of these therapies are now being used clinically to treat patients.

Education/Academic qualification

PhD in Microbiology, University of Alabama

BS in Biology, University of California at Irvine

Fingerprint

Dive into the research topics where Jerry Simecka is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

6 Similar Profiles

Network

Recent external collaboration on country level. Dive into details by clicking on the dots.

1 Active
38 Finished

Texas Center of Minority Health, Education, Research and Outreach - Admin/Development Core
Vishwanatha, J., Jones, H., He, J., Basha, R., Nandy, K., Mallet, R., Krishnamoorthy, R. & Simecka, J.
NIMHD: Natl Institute on Minority Health
23/09/17 → 31/05/22
Project: Research
FCCDC 2019-02: Model Development and Test Article Efficacy in a Disseminated Aspergillus and Cutaneous Fungal Infection (Aspergillus & Fusarium) Models
Simecka, J. & Weiss, W.
Fox Chase Chemical Diversity Center, Inc
22/10/19 → 21/10/20
Project: Research
Development and Validation of a Chronic Murine Lung Infection Model with S. Aureus
Simecka, J. & Weiss, W.
Janssen Pharmaceuticals
17/10/19 → 16/10/20
Project: Research
Pre-Clinical Services Agreements
Simecka, J. & Weiss, W.
Pre-Clinical Services Funding Pool
1/09/19 → 31/08/20
Project: Research
Development and Validation of a Chronic Murine Lung Infection Model with P. aeruginosa
Simecka, J. & Weiss, W.
Janssen Pharmaceuticals
18/04/19 → 17/04/20
Project: Research

2788 Citations
30 h-Index
72 Article
4 Review article
1 Comment/debate

Epidemic ribotypes of Clostridium (now Clostridioides) difficile are likely to be more virulent than non-epidemic ribotypes in animal models
Vitucci, J. C., Pulse, M., Tabor-Simecka, L. & Simecka, J., 5 Feb 2020, In: BMC Microbiology. 20, 1, 27.
Research output: Contribution to journal › Article › peer-review

Open Access
Clotam enhances anti-proliferative effect of vincristine in Ewing sarcoma cells
Shelake, S., Sankpal, U. T., Eslin, D., Bowman, W. P., Simecka, J. W., Raut, S., Ray, A. & Basha, R., 15 Feb 2019, In: Apoptosis. 24, 1-2, p. 21-32 12 p.
Research output: Contribution to journal › Article › peer-review
1 Scopus citations
Copper-tolfenamic acid: evaluation of stability and anti-cancer activity
Hurtado, M., Sankpal, U. T., Chhabra, J., Brown, D. T., Maram, R., Patel, R., Gurung, R. K., Simecka, J., Holder, A. A. & Basha, R., 15 Feb 2019, In: Investigational New Drugs. 37, 1, p. 27-34 8 p.
Research output: Contribution to journal › Article › peer-review
5 Scopus citations
Primary care clinics can be a source of exposure to virulent Clostridium (now Clostridioides) difficile: An environmental screening study of hospitals and clinics in Dallas-Fort Worth region
Simecka, J. W., Fulda, K. G., Pulse, M., Lee, J. H., Vitucci, J., Nguyen, P., Taylor, P., Filipetto, F., Espinoza, A. M. & Sharma, S., 1 Aug 2019, In: PLoS ONE. 14, 8, e0220646.
Research output: Contribution to journal › Article › peer-review

Open Access
1 Scopus citations
Activity of meropenem-vaborbactam against carbapenem- resistant enterobacteriaceae in a murine model of pyelonephritis
Weiss, W. J., Pulse, M. E., Nguyen, P., Peterson, K., Silva, J., Simecka, J. W., Valtierra, D., Sabet, M. & Griffith, D. C., Jan 2018, In: Antimicrobial agents and chemotherapy. 62, 1, e01439.
Research output: Contribution to journal › Article › peer-review
11 Scopus citations